1. Potent In vivo Anti–Breast Cancer Activity of IN-2001, a Novel Inhibitor of Histone Deacetylase, in MMTV/c-Neu Mice
    Ki E. Joung et al, 2006, Cancer Research CrossRef
  2. Global histone post-translational modifications and cancer: Biomarkers for diagnosis, prognosis and treatment?
    Shafqat Ali Khan, 2015, World Journal of Biological Chemistry CrossRef
  3. Effects of sodium butyrate-containing calcium sulfate bone graft on oral mucosa and bone tissue
    Hongjoo Park et al, 2022, Korean Journal of Dental Materials CrossRef
  4. Anti-Cancer Effect of 3-(4-dimethylamino phenyl)-N-hydroxy-2-propenamide in MCF-7 Human Breast Cancer
    Kyung Nan Min et al, 2012, Environmental Health and Toxicology CrossRef
  5. Mechanisms of Resistance to Histone Deacetylase Inhibitors and Their Therapeutic Implications
    Valeria R. Fantin et al, 2007, Clinical Cancer Research CrossRef
  6. Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactions
    Roberto R. Rosato et al, 2008, Molecular Cancer Therapeutics CrossRef
  7. Histone Deacetylase Inhibitors as Multitarget-Directed Epi-Drugs in Blocking PI3K Oncogenic Signaling: A Polypharmacology Approach
    Kasturi Ranganna et al, 2020, International Journal of Molecular Sciences CrossRef
  8. Potential of histone deacetylase inhibitors in the control and regulation of prostate, breast and ovarian cancer
    Siddhartha Das Pramanik et al, 2022, Frontiers in Chemistry CrossRef
  9. Histone tail modifications and noncanonical functions of histones: perspectives in cancer epigenetics
    Annamaria Hadnagy et al, 2008, Molecular Cancer Therapeutics CrossRef
  10. RNA Sequencing Analysis of Molecular Basis of Sodium Butyrate-Induced Growth Inhibition on Colorectal Cancer Cell Lines
    Qianwen Zhou et al, 2019, BioMed Research International CrossRef
  11. Oxidative Stress Suppresses Cellular Autophagy in Corneal Epithelium
    Yuanyuan Yin et al, 2018, Investigative Opthalmology & Visual Science CrossRef
  12. Gut Metabolites and Breast Cancer: The Continuum of Dysbiosis, Breast Cancer Risk, and Potential Breast Cancer Therapy
    Kayla Jaye et al, 2022, International Journal of Molecular Sciences CrossRef